Inotiv, Inc. (NOTVQ) vs XWELL, Inc. (XWEL)

Inotiv, Inc. and XWELL, Inc. are both Diagnostics & Research companies. XWELL, Inc. is the larger, with a market value of $7.6M against $2.8M — 2.7× the size. Inotiv, Inc. grew revenue faster over the last twelve months: 5.61% against −7.58%. Inotiv, Inc. has the higher net margin (−17.1% vs −117.8%) and the lower return on invested capital (−6.19% vs 0.00%). Across the 18 metrics below, Inotiv, Inc. leads on 10 and XWELL, Inc. on 8.

Valuation

Metric NOTVQ XWEL Diagnostics & Research median
P/E n/m n/m 33.95
P/S 0.00 0.27 4.87
P/B 0.00 0.92 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA 60.99 n/m 25.20
EV/Sales 1.57 0.30 5.66
Earnings yield (25,300.00%) (597.75%) (1.75%)
Free cash flow yield (2,858.05%) (178.41%) (0.13%)

Profitability

Metric NOTVQ XWEL Diagnostics & Research median
Gross margin 22.94% 34.34% 50.89%
Operating margin (9.48%) (61.31%) (8.57%)
Net margin (17.14%) (117.83%) (6.37%)
Free cash flow margin (1.95%) (47.65%) 0.00%
Return on equity (74.09%) (557.21%) (2.92%)
Return on assets (11.85%) (155.10%) (6.71%)
Return on invested capital (6.19%) 0.00% 0.00%

Growth

Metric NOTVQ XWEL Diagnostics & Research median
Revenue growth (TTM) 5.61% (7.58%) 7.69%
EPS growth (last fiscal year) 49.64% (38.80%) —
Revenue growth, 5-year CAGR 53.36% 28.35% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NOTVQ XWEL Diagnostics & Research median
Debt to equity 5.49 0.00 0.11
Current ratio 0.27 2.27 2.02
Net debt to EBITDA 12.68 (0.08) 0.78

Dividend

Metric NOTVQ XWEL Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric NOTVQ XWEL Diagnostics & Research median
Market cap 2.79m 7.64m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack